InvestorsHub Logo
Followers 2
Posts 79
Boards Moderated 0
Alias Born 06/23/2014

Re: None

Monday, 08/15/2016 1:25:04 PM

Monday, August 15, 2016 1:25:04 PM

Post# of 80490
This week Complete Rolling Submission of New Drug Application of Brigatinib with priority review?

...FDA informs the applicant of a Priority Review designation within 60 days of the receipt of the original BLA, NDA, or efficacy supplement...
link



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.